Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 5,506.00
+4.00 (0.07%)
Aug 5, 2026, 3:30 PM JST
Kobayashi Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 166,800 | 165,742 | 165,600 | 173,455 | 166,258 | 155,252 |
Revenue Growth | 3.14% | 0.09% | -4.53% | 4.33% | 7.09% | 3.15% |
Gross Profit Gross Profit Growth | 85,468 | 84,712 | 87,603 | 96,376 | 92,331 | 88,774 |
Operating Income Operating Income Growth | 13,677 | 14,845 | 24,710 | 25,627 | 26,506 | 25,951 |
Net Income Net Income Growth | 3,068 | 3,656 | 10,067 | 20,338 | 20,022 | 19,715 |
Earnings Per Share EPS Growth | 41.27 | 49.18 | 135.42 | 268.16 | 259.59 | 252.35 |
EPS Growth | -71.37% | -63.68% | -49.50% | 3.30% | 2.87% | 2.71% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Others Others Growth | 6,799 | 6,581 | 6,511 | 7,060 | 6,844 | 6,758 |
Unallocated Adjustment Unallocated Adjustment Growth | -12,701 | -12,174 | -11,676 | -14,277 | -14,823 | -13,596 |
International Business International Business Growth | 48,882 | 48,415 | 46,841 | 44,133 | 41,554 | 31,140 |
Domestic Business (Incl. Mail Order Business) Domestic Business (Incl. Mail Order Business) Growth | 123,820 | 122,920 | 123,924 | 136,539 | - | - |
Total Total Growth | 166,800 | 165,742 | 165,600 | 173,455 | 166,256 | 155,252 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 65,029 | 70,614 | 65,745 | 79,836 | 104,533 | 109,046 |
Total Debt Total Debt Growth | 727 | 678 | 846 | 987 | 792 | 630 |
Net Cash (Debt) Net Cash Growth | 64,302 | 69,936 | 64,899 | 78,849 | 103,741 | 108,416 |
Net Cash Growth | -3.29% | 7.76% | -17.69% | -23.99% | -4.31% | 15.77% |
Net Cash Per Share Net Cash Per Share Growth | 865.00 | 940.78 | 873.03 | 1039.65 | 1344.98 | 1387.72 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 25,590 | 11,246 | 18,360 | 31,914 | 22,419 |
Capital Expenditures CapEx Growth | - | -13,253 | -26,056 | -12,756 | -14,747 | -3,663 |
Free Cash Flow Free Cash Flow Growth | - | 12,337 | -14,810 | 5,604 | 17,167 | 18,756 |
Free Cash Flow Growth | - | - | - | -67.36% | -8.47% | -7.11% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 51.24% | 51.11% | 52.90% | 55.56% | 55.54% | 57.18% |
Operating Margin | 8.20% | 8.96% | 14.92% | 14.77% | 15.94% | 16.71% |
Pretax Margin | 2.24% | 2.26% | 8.40% | 15.89% | 16.81% | 17.80% |
Profit Margin | 1.84% | 2.21% | 6.08% | 11.72% | 12.04% | 12.70% |
FCF Margin | - | 7.44% | -8.94% | 3.23% | 10.33% | 12.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 106.000 | 104.000 | 102.000 | 101.000 | 90.000 | 83.000 |
Dividend Per Share Growth | 1.94% | 1.96% | 0.99% | 12.22% | 8.43% | 7.79% |
Dividend Yield | 1.93% | 1.93% | 1.68% | 1.56% | 1.06% | 0.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 133.41 | 110.37 | 46.01 | 24.77 | 32.48 | 35.73 |
Forward PE | 36.54 | 30.37 | 30.11 | 24.52 | 33.46 | 34.40 |
P/FCF Ratio | 33.18 | 32.71 | - | 89.91 | 37.88 | 37.56 |
PS Ratio | 2.45 | 2.44 | 2.80 | 2.91 | 3.91 | 4.54 |